Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Tianeptine vs amitriptyline for the treatment of irritable bowel syndrome with diarrhea: a multicenter, open-label, non-inferiority, randomized controlled study.

Sohn W, Lee OY, Kwon JG, Park KS, Lim YJ, Kim TH, Jung SW, Kim JI.

Neurogastroenterol Motil. 2012 Sep;24(9):860-e398. doi: 10.1111/j.1365-2982.2012.01945.x. Epub 2012 Jun 11.

2.
3.

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.

Andresen V, Montori VM, Keller J, West CP, Layer P, Camilleri M.

Clin Gastroenterol Hepatol. 2008 May;6(5):545-55. doi: 10.1016/j.cgh.2007.12.015. Epub 2008 Jan 31. Review.

4.

Tianeptine: a review of its use in depressive disorders.

Wagstaff AJ, Ormrod D, Spencer CM.

CNS Drugs. 2001;15(3):231-59. Review.

PMID:
11463130
5.

Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.

Shah E, Kim S, Chong K, Lembo A, Pimentel M.

Am J Med. 2012 Apr;125(4):381-93. doi: 10.1016/j.amjmed.2011.08.026. Review.

PMID:
22444104
6.

The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review.

Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS.

Am J Gastroenterol. 2009 Apr;104(4):1033-49; quiz 1050. doi: 10.1038/ajg.2009.25. Epub 2009 Mar 10. Review.

PMID:
19277023
7.

Treatment of irritable bowel syndrome.

Trinkley KE, Nahata MC.

J Clin Pharm Ther. 2011 Jun;36(3):275-82. doi: 10.1111/j.1365-2710.2010.01177.x. Epub 2010 Aug 24. Review.

PMID:
21545610
8.

2008 Clinical approach to irritable bowel syndrome.

Astegiano M, Pellicano R, Sguazzini C, Berrutti M, Simondi D, Reggiani S, Rizzetto M.

Minerva Gastroenterol Dietol. 2008 Sep;54(3):251-7. Review.

PMID:
18614974
9.

[Therapeutic effects of tianeptine in patients with depression and anxiety disorders with or without associated alcoholism].

Marey C, Ganry H, Delalleau B, Kamoun A.

Presse Med. 1991 Nov 14;20(37):1828-36. Review. French.

PMID:
1836615
10.

Irritable bowel syndrome--diarrhoea.

Wald A.

Best Pract Res Clin Gastroenterol. 2012 Oct;26(5):573-80. doi: 10.1016/j.bpg.2012.11.002. Review.

PMID:
23384803
11.

Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work.

Schoenfeld P.

Gastroenterol Clin North Am. 2005 Jun;34(2):319-35, viii. Review.

PMID:
15862938
12.

Diagnostic and therapeutic strategies in the irritable bowel syndrome.

Cremonini F, Talley NJ.

Minerva Med. 2004 Oct;95(5):427-41. Review.

PMID:
15467518
13.

Evaluating the functional net value of pharmacologic agents in treating irritable bowel syndrome.

Shah E, Pimentel M.

Aliment Pharmacol Ther. 2014 May;39(9):973-83. doi: 10.1111/apt.12692. Epub 2014 Mar 11. Review.

14.

Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.

Atluri DK, Chandar AK, Bharucha AE, Falck-Ytter Y.

Neurogastroenterol Motil. 2014 Apr;26(4):499-509. doi: 10.1111/nmo.12292. Epub 2013 Dec 18. Review.

15.

Treatment of abdominal pain in irritable bowel syndrome.

Vanuytsel T, Tack JF, Boeckxstaens GE.

J Gastroenterol. 2014 Aug;49(8):1193-205. doi: 10.1007/s00535-014-0966-7. Epub 2014 May 21. Review.

PMID:
24845149
16.

Selective serotonin reuptake inhibitors for the treatment of irritable bowel syndrome.

Bundeff AW, Woodis CB.

Ann Pharmacother. 2014 Jun;48(6):777-84. doi: 10.1177/1060028014528151. Epub 2014 Mar 20. Review.

PMID:
24651166
17.

Update on the Management of Diarrhea-Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline.

Rivkin A, Rybalov S.

Pharmacotherapy. 2016 Mar;36(3):300-16. doi: 10.1002/phar.1712. Epub 2016 Mar 11. Review.

PMID:
26971716
18.

Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome.

Camilleri M.

Expert Opin Pharmacother. 2013 Jun;14(9):1151-60. doi: 10.1517/14656566.2013.794223. Epub 2013 Apr 27. Review.

PMID:
23621801
19.

[Pharmacological treatment of the irritable bowel syndrome: a technical review].

Remes-Troche JM, Gómez-Escudero O, Nogueira-de Rojas JR, Carmona-Sánchez R, Pérez-Manauta J, López-Colombo A, Sanjurjo-García JL, Noble-Lugo A, Chávez-Barrera JA, González-Martínez M.

Rev Gastroenterol Mex. 2010;75(1):42-66. Review. Spanish.

PMID:
20423782
20.

Atypical antipsychotics as a possible treatment option for irritable bowel syndrome.

Pae CU, Lee SJ, Han C, Patkar AA, Masand PS.

Expert Opin Investig Drugs. 2013 May;22(5):565-72. doi: 10.1517/13543784.2013.782392. Epub 2013 Mar 19. Review.

PMID:
23506326
Items per page

Supplemental Content

Write to the Help Desk